The EV-HIV assay, a point-of-care lateral flow immunoassay to accurately identify HIV infection from blood-based extracellular vesicles
Award Notice Posted
- Solicitation number
- 75N93023C00007
- Agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Awarded
- to Intuitive Biosciences Inc.
- Set-aside
- Total Small Business
Opportunity facts
- Contract number
- 75N93023C00007 Federal contract award
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Place of performance
- Madison, Wisconsin 53717, United States
Notice details come from SAM.gov. Updated .
About this opportunity
INTUITIVE BIOSCIENCES INC was awarded a contract by the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases on August 1, 2023 to develop the EV-HIV assay, a point-of-care lateral flow immunoassay to accurately identify HIV infection from blood-based extracellular vesicles under contract number 75N93023C00007 valued at $306,206. This diagnostic tool will support efforts to more precisely identify HIV infection status through analysis of extracellular vesicles and help address the HIV/AIDS epidemic.
Notice text
Awarded contract 75N93023C00007 to INTUITIVE BIOSCIENCES INC for 306206.00 on 2023-08-01.
Notice history
6 of 8 notices listed here. See the rest on GovTribe.
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity